GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (FRA:N1A) » Definitions » EV-to-EBIT

Navamedic ASA (FRA:N1A) EV-to-EBIT : 38.95 (As of May. 20, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Navamedic ASA EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Navamedic ASA's Enterprise Value is €62.63 Mil. Navamedic ASA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €1.61 Mil. Therefore, Navamedic ASA's EV-to-EBIT for today is 38.95.

The historical rank and industry rank for Navamedic ASA's EV-to-EBIT or its related term are showing as below:

FRA:N1A' s EV-to-EBIT Range Over the Past 10 Years
Min: -118   Med: -9.2   Max: 304.58
Current: 39.14

During the past 13 years, the highest EV-to-EBIT of Navamedic ASA was 304.58. The lowest was -118.00. And the median was -9.20.

FRA:N1A's EV-to-EBIT is ranked worse than
85.19% of 81 companies
in the Medical Distribution industry
Industry Median: 12.94 vs FRA:N1A: 39.14

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Navamedic ASA's Enterprise Value for the quarter that ended in Dec. 2023 was €68.17 Mil. Navamedic ASA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €1.61 Mil. Navamedic ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2.36%.


Navamedic ASA EV-to-EBIT Historical Data

The historical data trend for Navamedic ASA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navamedic ASA EV-to-EBIT Chart

Navamedic ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.45 -21.30 117.73 13.91 41.51

Navamedic ASA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.73 - 13.91 - 41.51

Competitive Comparison of Navamedic ASA's EV-to-EBIT

For the Medical Distribution subindustry, Navamedic ASA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navamedic ASA's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Navamedic ASA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Navamedic ASA's EV-to-EBIT falls into.



Navamedic ASA EV-to-EBIT Calculation

Navamedic ASA's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=62.627/1.608
=38.95

Navamedic ASA's current Enterprise Value is €62.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Navamedic ASA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €1.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navamedic ASA  (FRA:N1A) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Navamedic ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=1.608/68.1696
=2.36 %

Navamedic ASA's Enterprise Value for the quarter that ended in Dec. 2023 was €68.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Navamedic ASA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €1.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navamedic ASA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Navamedic ASA (FRA:N1A) Business Description

Traded in Other Exchanges
Address
Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255
Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (FRA:N1A) Headlines

No Headlines